HomeCompareTSVT vs NNN

TSVT vs NNN: Dividend Comparison 2026

TSVT yields 40.00% · NNN yields 5.68%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TSVT wins by $206.3K in total portfolio value
10 years
TSVT
TSVT
● Live price
40.00%
Share price
$5.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$231.9K
Annual income
$39,181.04
Full TSVT calculator →
NNN
NNN REIT Inc.
● Live price
5.68%
Share price
$41.89
Annual div
$2.38
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.6K
Annual income
$2,637.42
Full NNN calculator →

Portfolio growth — TSVT vs NNN

📍 TSVT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTSVTNNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TSVT + NNN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TSVT pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TSVT
Annual income on $10K today (after 15% tax)
$3,400.00/yr
After 10yr DRIP, annual income (after tax)
$33,303.88/yr
NNN
Annual income on $10K today (after 15% tax)
$482.93/yr
After 10yr DRIP, annual income (after tax)
$2,241.81/yr
At 15% tax rate, TSVT beats the other by $31,062.08/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TSVT + NNN for your $10,000?

TSVT: 50%NNN: 50%
100% NNN50/50100% TSVT
Portfolio after 10yr
$128.7K
Annual income
$20,909.23/yr
Blended yield
16.24%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

TSVT
Analyst Ratings
4
Buy
6
Hold
Consensus: Hold
Price Target
$3.50
-30.0% upside vs current
Range: $2.00 — $5.00
Altman Z
-1.0
Piotroski
2/9
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+7.3% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TSVT buys
0
NNN buys
0
No recent congressional trades found for TSVT or NNN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTSVTNNN
Forward yield40.00%5.68%
Annual dividend / share$2.00$2.38
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%8.6%
Portfolio after 10y$231.9K$25.6K
Annual income after 10y$39,181.04$2,637.42
Total dividends collected$174.4K$13.7K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldHold
Analyst price target$3.50$44.93

Year-by-year: TSVT vs NNN ($10,000, DRIP)

YearTSVT PortfolioTSVT Income/yrNNN PortfolioNNN Income/yrGap
1← crossover$14,700$4,000.00$10,737$617.02+$4.0KTSVT
2$21,224$5,495.33$11,577$710.93+$9.6KTSVT
3$30,125$7,415.26$12,538$822.59+$17.6KTSVT
4$42,071$9,836.48$13,645$956.06+$28.4KTSVT
5$57,854$12,838.17$14,925$1,116.51+$42.9KTSVT
6$78,403$16,499.54$16,415$1,310.57+$62.0KTSVT
7$104,788$20,897.28$18,158$1,546.77+$86.6KTSVT
8$138,226$26,102.79$20,213$1,836.20+$118.0KTSVT
9$180,082$32,179.61$22,649$2,193.37+$157.4KTSVT
10$231,869$39,181.04$25,558$2,637.42+$206.3KTSVT

TSVT vs NNN: Complete Analysis 2026

TSVTStock

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.

Full TSVT Calculator →

NNNREIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →
📬

Get this TSVT vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TSVT vs SCHDTSVT vs JEPITSVT vs OTSVT vs KOTSVT vs MAINTSVT vs ADCTSVT vs EPRTTSVT vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.